Language and Difference in Herodotus by Edward Nolan A dissertation submitted in partial fulfillment of the requirements for the
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromb
![Abstracts for the UIP XIX World Congress of Phlebology, 12–16 September 2022, Istanbul, Turkey, 2022 Abstracts for the UIP XIX World Congress of Phlebology, 12–16 September 2022, Istanbul, Turkey, 2022](https://journals.sagepub.com/cms/10.1177/02683555221110363/asset/images/large/10.1177_02683555221110363-fig1.jpeg)
Abstracts for the UIP XIX World Congress of Phlebology, 12–16 September 2022, Istanbul, Turkey, 2022
![Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial - The Lancet Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/4eec1a67-85ef-43ef-adaf-d2b47cb9bed0/gr2_lrg.jpg)
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial - The Lancet
![IJERPH | Free Full-Text | Statistical Measurements and Club Effects of High-Quality Development in Chinese Manufacturing IJERPH | Free Full-Text | Statistical Measurements and Club Effects of High-Quality Development in Chinese Manufacturing](https://www.mdpi.com/ijerph/ijerph-19-16228/article_deploy/html/images/ijerph-19-16228-g004.png)